Skip to content
10-Q

Quarterly Report

Lipella Pharmaceuticals Inc. LIPO

0001753926-25-001347

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 13, 2025 4.62M sh
Shares Diluted Q2 2025 · Jun 30, 2025 4.31M sh
Shares Diluted Q2 2025 · Jun 30, 2025 3.19M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 950.67K sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 931.09K sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$2.86M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$2.31M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $2.78M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $2.18M
Stockholders Equity Q2 2025 · Jun 30, 2025 $2.74M
Stockholders Equity Q2 2025 · Mar 31, 2025 $4.08M
Stockholders Equity Q2 2025 · Dec 31, 2024 $1.92M
Stockholders Equity Q2 2025 · Jun 30, 2024 $1.7M
Stockholders Equity Q2 2025 · Mar 31, 2024 $2.56M
Stockholders Equity Q2 2025 · Dec 31, 2023 $3.14M
Current Liabilities Q2 2025 · Jun 30, 2025 $746.9K
Current Liabilities Q2 2025 · Dec 31, 2024 $754.42K
Total Liabilities Q2 2025 · Jun 30, 2025 $978.53K
Total Liabilities Q2 2025 · Dec 31, 2024 $754.42K
Current Assets Q2 2025 · Jun 30, 2025 $3.44M
Current Assets Q2 2025 · Dec 31, 2024 $2.62M
Total Assets Q2 2025 · Jun 30, 2025 $3.72M
Total Assets Q2 2025 · Dec 31, 2024 $2.67M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.31
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.83
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$0.99
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$2.29
Eps Basic Q2 2025 · Jun 30, 2025 −$0.31
Eps Basic Q2 2025 · Jun 30, 2025 −$0.83
Eps Basic restated Q2 2025 · Jun 30, 2024 −$0.99
Eps Basic restated Q2 2025 · Jun 30, 2024 −$2.29
Sga Expense Q2 2025 · Jun 30, 2025 $651.72K
Sga Expense Q2 2025 · Jun 30, 2025 $1.12M
Sga Expense Q2 2025 · Jun 30, 2024 $427.06K
Sga Expense Q2 2025 · Jun 30, 2024 $947.99K
Rd Expense Q2 2025 · Jun 30, 2025 $791.58K
Rd Expense Q2 2025 · Jun 30, 2025 $1.79M
Rd Expense Q2 2025 · Jun 30, 2024 $661.56K
Rd Expense Q2 2025 · Jun 30, 2024 $1.5M
Net Income Q2 2025 · Jun 30, 2025 −$1.33M
Net Income Q2 2025 · Jun 30, 2025 −$2.63M
Net Income Q2 2025 · Mar 31, 2025 −$1.31M
Net Income Q2 2025 · Jun 30, 2024 −$938.15K
Net Income Q2 2025 · Jun 30, 2024 −$2.13M
Net Income Q2 2025 · Mar 31, 2024 −$1.19M
Operating Income Q2 2025 · Jun 30, 2025 −$1.36M
Operating Income Q2 2025 · Jun 30, 2025 −$2.68M
Operating Income Q2 2025 · Jun 30, 2024 −$952.19K
Operating Income Q2 2025 · Jun 30, 2024 −$2.17M
Revenue Q2 2025 · Jun 30, 2025 $86.73K
Revenue Q2 2025 · Jun 30, 2025 $216.12K
Revenue Q2 2025 · Jun 30, 2024 $136.43K
Revenue Q2 2025 · Jun 30, 2024 $282.31K